Free Trial

Motus GI Q4 2023 Earnings Report

Motus GI logo
$0.0001 0.00 (-50.00%)
As of 02/21/2025 02:12 PM Eastern

Motus GI EPS Results

Actual EPS
-$4.13
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Motus GI Revenue Results

Actual Revenue
$0.06 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Motus GI Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Motus GI Earnings Headlines

A strange twist 500 miles from Washington
Energy is life. And this year, it could also make national heroes out of President Trump and VP Vance. With the news cycle dominated by the tariffs… Elon’s DOGE… and the Russia peace talks… Hidden in America's forgotten towns, a groundbreaking energy discovery is taking shape. And it's happening right in our own backyard – in the heart of Appalachia.
See More Motus GI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Motus GI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Motus GI and other key companies, straight to your email.

About Motus GI

Motus GI (NASDAQ:MOTS) operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

View Motus GI Profile

More Earnings Resources from MarketBeat